BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 30291776)

  • 21. Studies on Papanicolaou staining. I. Visible-light spectra of stained cervical cells.
    Galbraith W; Marshall PN; Lee ES; Bacus JW
    Anal Quant Cytol; 1979; 1(3):160-8. PubMed ID: 94521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
    Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
    Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of three different methods for automated classification of cervical cells.
    Palcic B; MacAulay C; Shlien S; Treurniet W; Tezcan H; Anderson G
    Anal Cell Pathol; 1992 Nov; 4(6):429-41. PubMed ID: 1280993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applicability of the Bethesda System 2001 to a public health setting.
    Prandi S; Beccati D; De Aloysio G; Fulgenzi P; Gabrielli M; Ghirardini C; Rivasi F; Saragoni L; de Bianchi PS; Bucchi L
    Cancer; 2006 Oct; 108(5):271-6. PubMed ID: 16948127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of screening and preventive strategies for cervical cancer in India.
    Patro BK; Nongkynrih B
    Indian J Public Health; 2007; 51(4):216-21. PubMed ID: 18232160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the QBC method to detect malaria infections in field surveys.
    Oloo AJ; Ondijo SO; Genga IO; Boriga DA; Owaga ML; Ngare D; Gathecha E
    East Afr Med J; 1994 May; 71(5):297-9. PubMed ID: 7925060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
    Wong LP; Wong YL; Low WY; Khoo EM; Shuib R
    Singapore Med J; 2009 Jan; 50(1):49-53. PubMed ID: 19224084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A project to improve the screening rate of pap smear for cervical cancer].
    Lin HH; Chen SH; Jeng SY; Chen HM
    Hu Li Za Zhi; 2007 Feb; 54(1):62-9. PubMed ID: 17340549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved cervical cancer screening in premenopausal women by combination of Pap smear and speculoscopy.
    Twu NF; Chen YJ; Wang PH; Yu BK; Lai CR; Chao KC; Yuan CC; Yen MS
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):114-8. PubMed ID: 16797826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thionine-Feulgen-Congo red staining of cervical smears for the BioPEPR image-analysis system.
    Oud PS; Zahniser DJ; Raaijmakers MC; Vooijs PG; Van de Walle RT
    Anal Quant Cytol; 1981 Dec; 3(4):289-94. PubMed ID: 6174058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nominated texture based cervical cancer classification.
    Mariarputham EJ; Stephen A
    Comput Math Methods Med; 2015; 2015():586928. PubMed ID: 25649913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
    Chen MK; Hung HF; Duffy S; Yen AM; Chen HH
    J Eval Clin Pract; 2011 Dec; 17(6):1050-8. PubMed ID: 21679279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.
    Guo F; Hirth JM; Berenson AB
    Prev Med; 2015 Dec; 81():427-32. PubMed ID: 26500084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical cancer screening among Lebanese women.
    Bou-Orm IR; Sakr RE; Adib SM
    Rev Epidemiol Sante Publique; 2018 Feb; 66(1):1-6. PubMed ID: 29249573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening and early diagnosis of cervical cancer].
    Baldauf JJ; Fender M; Baulon E
    Rev Prat; 2010 Feb; 60(2):213-8. PubMed ID: 20225560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
    Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contextual analysis and intermediate cell markers enhance high-resolution cell image analysis for automated cervical smear diagnosis.
    Zahniser DJ; Wong KL; Brenner JF; Ball HG; Garcia GL; Hutchinson ML
    Cytometry; 1991; 12(1):10-4. PubMed ID: 1705494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.